For FY March 2026 Q3 cumulative (April–December 2025), results were Revenue ¥19.6B (YoY +¥0.9B +4.9%), Operating Income ¥1.0B (turned profitable from -¥0.9B in the prior-year period, +¥1.9B), Ordinary Income ¥0.6B (turned profitable from -¥1.2B in the prior-year period, +¥1.8B), and Net Income ¥0.5B (turned profitable from -¥1.3B in the prior-year period, +¥1.8B). Although Revenue was only slightly higher, the company achieved profitability at all profit levels thanks to progress in profit structure reforms. Operating margin improved significantly to 4.9% (prior year -4.8%), and EPS was ¥4.31 (prior year -¥10.26). Total assets were ¥39.8B (down ¥2.0B from ¥41.8B at the prior fiscal year-end), and net assets were ¥2.8B (up ¥0.6B from ¥2.2B at the prior fiscal year-end), lifting the Equity Ratio to 6.9%, though it remains low.
Revenue of ¥19.6B (YoY +4.9%) was driven by an increase in meal count sold in the MFD Business and channel expansion in retail for the CID Business. The MFD Business grew a steady +1.5% YoY, while the CID Business recorded strong growth of +60.9% YoY. Conversely, the Marketing Business declined -18.3% YoY, limiting the company-wide growth rate. Gross profit was ¥9.5B with a high gross margin of 48.3%.
Profitability: The turnaround to Operating Income of ¥1.0B (an improvement of +¥1.9B from -¥0.9B in the prior-year period) was mainly due to a lower SG&A ratio. SG&A was ¥8.5B (YoY -¥0.9B), bringing the SG&A ratio to 43.3% (an improvement of -9.4pt from 52.7% a year earlier). By segment, reductions in advertising expenses in the MFD Business (+¥0.02B improvement), cost ratio improvement in the CID Business (+¥0.30B improvement), and sustained high profitability in the Marketing Business (operating margin 75.2%) contributed. Non-operating expenses were ¥0.4B, with interest expense of ¥0.4B weighing on profits. Ordinary Income was ¥0.6B and Net Income was ¥0.5B, broadly in line with Operating Income, indicating limited impact from one-off factors. In sum, this was a revenue growth and profit recovery with a turnaround to profitability at operating, ordinary, and net levels.
MFD Business (home delivery of medical meals) posted Revenue of ¥15.5B (78.6% of total) and Operating Income of ¥2.5B (operating margin 16.0%), positioning it as the core business. Versus the prior-year period, Revenue was +1.5% and Operating Income -7.3%, a slight increase in sales and decrease in profit, but quarterly trends continue to recover. With 25,066 active members, monthly ARPU of ¥16,351, and 5,733 subscription-plan members, the membership base is stable. CID Business (frozen prepared foods e-commerce and retail sales) posted Revenue of ¥1.8B (9.2% of total) and an Operating Loss of ¥1.9B; while still loss-making, the loss narrowed by ¥0.7B from an Operating Loss of ¥2.6B in the prior-year period. Revenue grew a strong +60.9% YoY, with progress in retail channel expansion (newly established sales department) and cost ratio improvement. Marketing Business (marketing support leveraging a network of medical institutions) posted Revenue of ¥3.2B (16.3% of total) and Operating Income of ¥2.4B (operating margin 75.2%), maintaining high profitability. Versus the prior-year period, Revenue was -18.3% and Operating Income -16.7%, i.e., lower sales and profits, but Q4 has a large order backlog and is expected to post an all-time high quarterly revenue. The main drivers of company-wide profit growth were SG&A reductions in the MFD Business and narrower losses in the CID Business, with improved profitability in the core business propelling the recovery.
Profitability: ROE 19.6% (prior year -58.6%), operating margin 4.9% (prior year -4.8%), gross margin 48.3% (prior year 49.3%). The improvement in ROE stems from the return to profitability but relies heavily on financial leverage of 14.42x (prior year 18.65x). While operating margin exceeds the sector median of 3.9%, interest burden lowers the ordinary income margin to 2.8%.
Cash quality: Operating Cash Flow data are not disclosed, so OCF/Net Income cannot be calculated. Cash and deposits were ¥4.9B, a decrease of ¥2.7B from ¥7.6B at the prior fiscal year-end (-35.1%), suggesting cash outflows due to increased working capital and interest payments. Accounts receivable were ¥1.2B (¥0.9B at prior fiscal year-end, +35.7%), and inventories were ¥2.5B (¥1.7B at prior fiscal year-end, +49.5%), indicating higher working capital.
Investment efficiency: Capex and depreciation are not disclosed, so metrics cannot be calculated. Property, plant and equipment were ¥0.5B (¥0.5B at prior fiscal year-end), suggesting limited capital expenditures.
Financial soundness: Equity Ratio 6.9% (prior fiscal year-end 5.3%), current ratio 227.3% (prior fiscal year-end 252.9%), quick ratio 172.2% (prior fiscal year-end 172.6%). The Equity Ratio remains far below the sector median of 48.9%, indicating a fragile capital base. Interest-bearing debt is ¥32.4B (long-term borrowings), with D/E ratio of 13.42x and Debt/Capital ratio of 92.2%, indicating continued high leverage. Interest coverage is 2.22x (Operating Income/interest expense), leaving limited buffer against interest burden.
Full-year guidance is maintained at Revenue ¥29.9B (YoY +21.5%), Operating Income ¥0.9B, Ordinary Income ¥0.3B, and Net Income ¥0.3B. Progress versus Q3 cumulative is 65.5% for Revenue, 112.0% for Operating Income, 198.0% for Ordinary Income, and 204.0% for Net Income. Profit levels below Operating Income are well above the standard 75% progress, implying an assumption that Q4 profitability will be lower than Q3. The company expects an all-time high quarterly revenue in Q4 and notes upside potential. By segment, progress rates are: MFD Business Revenue 71% and Operating Income 78%; CID Business Revenue 46% and Operating Loss 62% (progress versus loss forecast); Marketing Business Revenue 62% and Operating Income 63%. Although the CID Business is behind on revenue progress, it plans to catch up in Q4 through retail channel expansion and product lineup revisions for e-commerce. As Operating Income progress stands at 112%, an upward revision is conceivable, but the company maintains guidance, indicating a cautious stance.
The Q2-end dividend was not implemented at ¥0, and the year-end dividend forecast is also ¥0, indicating a no-dividend policy for the full year. Payout Ratio is not applicable. There is no mention of share buybacks. While shareholder returns are not being implemented at present, the company announced plans to launch a new shareholder benefit program from the end of March 2026. Details of the benefits have not been disclosed, but it seeks to strengthen engagement with shareholders through events such as a tasting event (scheduled for July 12, 2025) and a health seminar by a registered dietitian (scheduled for August 23, 2025). With an Equity Ratio of 6.9% and D/E ratio of 13.42x, financial leverage is high, and strengthening equity through retained earnings is a priority. Resumption of dividends will require sustained profitability, improvement in the Equity Ratio, and reduction of interest-bearing debt.
Short term: In Q4, the Marketing Business is expected to post an all-time high quarterly revenue by working through its order backlog. The CID Business will advance retail channel expansion via the newly established sales department and enhance quality as a high-end frozen food brand through product revisions for e-commerce. The launch of a new shareholder benefit program (end-March 2026) and shareholder events (July and August 2025) aim to expand the shareholder base. Upside potential exists given a 112% progress rate for Operating Income versus full-year guidance.
Long term: Expansion of a low-cost customer acquisition model in the MFD Business leveraging a network of medical institutions (approx. 20,000 locations). Achieving profitability in the CID Business (currently an Operating Loss of ¥1.9B, improving from a full-year forecast Operating Loss of ¥2.9B). Deepening the differentiation strategy of the Marketing Business through expert recommendations. Strengthening the organizational foundation through human capital management (paid leave utilization rate target 90%, monthly average overtime target 18 hours or less). Recovery in financial soundness through lower leverage and improved Equity Ratio.
Industry positioning (reference information; our research) The company’s operating margin of 4.9% is 1.0pt above the sector median of 3.9% (IQR: 2.0%–9.5%), placing it above average within the sector. Revenue growth of 4.9% is 1.8pt below the sector median of 6.7% (IQR: 0.4%–11.7%), indicating below-average growth within the sector. ROE of 19.6% is 16.7pt above the sector median of 2.9% (IQR: 0.8%–7.4%), but this is largely the result of financial leverage of 14.42x. An Equity Ratio of 6.9% is 42.0pt below the sector median of 48.9% (IQR: 37.6%–62.1%), likely among the lowest in the sector. A current ratio of 2.27x is 0.39x above the sector median of 1.88x (IQR: 1.33x–2.73x), indicating above-average short-term liquidity. A net margin of 2.8% is 0.6pt above the sector median of 2.2% (IQR: 0.5%–6.3%), but its advantage is limited by interest burden.
(Industry: Retail, comparison: Q3 2025, N=12 companies, Source: our compilation)
Financial risk from high leverage: With a D/E ratio of 13.42x, Debt/Capital ratio of 92.2%, and interest-bearing debt of ¥32.4B versus equity of ¥2.8B, leverage is extremely high. Interest expense of ¥0.4B equals 44% of Operating Income of ¥1.0B, and interest coverage is 2.22x, indicating low resilience to rising interest rates or downside in earnings. Refinancing risk on long-term borrowings and deterioration in funding conditions due to changes in the financial environment would directly impact results.
Liquidity risk from increased working capital: With accounts receivable +35.7% and inventories +49.5%, working capital has surged, while cash and deposits declined by ¥2.7B from the prior fiscal year-end (-35.1%) to ¥4.9B. If inventory turnover worsens or collection terms deteriorate, OCF generation could weaken further, pressuring short-term liquidity.
Risk of delayed profitability in the CID Business: The CID Business has an Operating Loss of ¥1.9B (a full-year forecast loss of ¥2.9B). Its earnings improvement assumes retail channel expansion and product lineup revisions for e-commerce. If channel expansion lags or cost ratio improvements slow, losses may persist and weigh on company-wide earnings.
Progress in profit structure reforms and return to profitability: The turnaround from an Operating Loss of ¥0.9B in the prior-year period to Operating Income of ¥1.0B, and a 9.4pt improvement in the SG&A ratio, indicate that profit structure reforms are beginning to take hold. If reductions in advertising expenses in the MFD Business and cost ratio improvements in the CID Business become entrenched, a shift toward sustainable profitability is expected.
Financial leverage and a fragile capital base: An Equity Ratio of 6.9%, D/E ratio of 13.42x, and interest coverage of 2.22x indicate high financial risk. The elevated ROE of 19.6% depends on financial leverage, while the business’s intrinsic capital efficiency (net margin 2.8%, total asset turnover 0.492x) is limited. Reducing interest burden and strengthening equity are medium- to long-term priorities.
Working capital management and room to improve cash generation: The sharp increases in accounts receivable and inventories (+35.7% and +49.5%, respectively) and the decrease in cash and deposits (-35.1%) suggest deteriorating working capital efficiency. Improving inventory turnover and accelerating receivables collection will be key to enhancing OCF generation and financial stability.
This report is an automatically generated earnings analysis produced by AI that integrates XBRL earnings release data and PDF results briefing materials. It does not constitute a recommendation to invest in any specific security. The industry benchmarks are reference information compiled by our firm based on publicly available financial data. Investment decisions are your own responsibility; consult a professional as needed.
Operating CF: Not calculable due to lack of disclosed data, but the decline in cash and deposits to ¥4.9B (from ¥7.6B at the prior fiscal year-end, -¥2.7B, -35.1%) suggests that cash generation from operating activities has been pressured by increased working capital and interest payments. Working capital increases of accounts receivable +¥0.6B and inventories +¥0.8B are factors depressing OCF.
Investing CF: Details are unknown due to lack of disclosure on capital expenditures. Property, plant and equipment were flat versus the prior fiscal year-end, suggesting no major capital investments.
Financing CF: Interest-bearing debt (long-term borrowings) stood at ¥32.4B, a slight increase from ¥32.0B at the prior fiscal year-end. Interest expense of ¥0.4B was a cash outflow in financing CF. No dividends were paid, and there was no mention of share buybacks.
FCF: Not calculable due to lack of disclosure of OCF and capital expenditures. Given the decline in cash and increase in working capital, FCF is inferred to be negative or limited.
Cash generation assessment: Requires monitoring. Weak cash generation is due to three factors: declining cash, increasing working capital, and a high interest burden.